This shows that RNF5 silencing can effectively inhibit viral replication, control the infection, slow down the secretion of proinflammatory cytokines, and reduce inflammatory-cell infiltration in the corneal tissue in the later stages of the disease, thereby relieving corneal tissue damage caused by excessive autoimmune responses in the late stage of HSK. Here, RNF5 is linked to infection.